JAY BERKOWITZ: Open Payments
NPI 1255382396 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,082 in 265 payments from 19 companies in 2025. Trend: 2023 $2,860 · 2024 $3,963 · 2025 $3,082
Food & beverage: $3,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $742 |
| Corium, LLC | 55 | $672 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $295 |
| Axsome Therapeutics, Inc. | 21 | $215 |
| Collegium Pharmaceutical, Inc. | 20 | $204 |
| Teva Pharmaceuticals USA, Inc. | 16 | $202 |
| Alkermes, Inc. | 8 | $196 |
| Otsuka America Pharmaceutical, Inc. | 12 | $174 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
Products named: VRAYLAR, Azstarys, CAPLYTA, Auvelity, Jornay PM, ARISTADA, AUSTEDO XR, REXULTI.
Industry payments across CT — which companies pay providers there.
